These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30098846)

  • 1. Effects of cold atmospheric plasma (CAP) on bacteria and mucosa of the upper aerodigestive tract.
    Becker S; Zimmermann JL; Baumeister P; Brunner TF; Shimizu T; Li YF; Morfill GE; Harréus U; Welz C
    Auris Nasus Larynx; 2019 Apr; 46(2):294-301. PubMed ID: 30098846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
    Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].
    López H; Sader H; Amábile C; Pedreira W; Muñoz Bellido JL; García Rodríguez JA;
    Rev Esp Quimioter; 2002 Dec; 15(4):325-34. PubMed ID: 12587037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders.
    Salari MH; Amine G; Shirazi MH; Hafezi R; Mohammadypour M
    Clin Microbiol Infect; 2006 Feb; 12(2):194-6. PubMed ID: 16441463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
    Nilius AM; Hensey-Rudloff DM; Reimann MA; Flamm RK
    J Antimicrob Chemother; 2002 May; 49(5):831-6. PubMed ID: 12003979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Watanabe A; Aoki N; Matsumoto T; Yoshida M; Sato J; Wakamura T; Sunakawa K; Kadota J; Kiyota H; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Takeuchi K; Takeda H; Ikeda H; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Morino E; Takasaki J; Mezaki K; Chonabayashi N; Tanaka C; Sugiura H; Goto H; Saraya T; Kurai D; Katono Y; Inose R; Niki Y; Takuma T; Kudo M; Ehara S; Sato Y; Tsukada H; Watabe N; Honma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Seki M; Hamaguchi S; Toyokawa M; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Nakamura T; Mikasa K; Kasahara K; Ui K; Fukuda S; Nakamura A; Morimura M; Yamashita M; Takesue Y; Wada Y; Sugimoto K; Kusano N; Nose M; Mihara E; Kuwabara M; Doi M; Watanabe Y; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Ota T; Fujita M; Honda J; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Kaku N; Fujita J; Higa F; Tateyama M
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat.
    Matthews D; Adegoke O; Shephard A
    BMC Res Notes; 2020 Feb; 13(1):99. PubMed ID: 32093784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clarithromycin sensitivity survey in the United Kingdom using Stokes' method.
    Humphreys JE; Smith EG; Coles SJ
    J Antimicrob Chemother; 1993 Aug; 32(2):341-2. PubMed ID: 8226438
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance in Streptococci and Haemophilus influenzae.
    Bozdogan B; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial effect of Zingiber officinale and Garcinia kola on respiratory tract pathogens.
    Akoachere JF; Ndip RN; Chenwi EB; Ndip LM; Njock TE; Anong DN
    East Afr Med J; 2002 Nov; 79(11):588-92. PubMed ID: 12630492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004).
    Inoue M; Farrell DJ; Kaneko K; Akizawa K; Fujita S; Kaku M; Igari J; Yamaguchi K; Yamanaka K; Murase M; Asari S; Hirakata Y; Baba H; Itaha H
    Microb Drug Resist; 2008 Jun; 14(2):109-17. PubMed ID: 18500920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.